23.08.2023
Publications category: Program strategies and efficiencies
23.08.2023
Translating Pharmacometrics to a Pharmacoeconomic Model of COPD
23.08.2023
Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1 – A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical Trials
14.06.2023
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
14.06.2023
Overview of Authorized Drug Products for Subcutaneous Administration: Pharmaceutical, Therapeutic, and Physicochemical Properties
14.06.2023
Physiological Based Pharmacokinetic and Biopharmaceutics Modelling of Subcutaneously Administered Compounds – An Overview of In Silico Models
14.06.2023
Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report
14.06.2023
Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies
14.06.2023
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report
14.06.2023
Modelling and Simulation of Neurological Endpoints (Modified Rankin Scale [mRS] and National Institute of Health Stroke Scale [NIHSS]) to Aid Clinical Trial Design in Intracerebral Hemorrhage (ICH)
14.06.2023